CLASS III ONGOING Drug recall · Reported 1 Oct 2025 · FDA Enforcement Report

Dextroamphetamine Saccharate recalled by Granules Pharmaceuticals

Granules Pharmaceuticals is recalling Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine, distributed nationwide in the US. The recall was initiated on 28 Aug 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: GPC250178A, Exp Date: 06-22-2027
NDC70010-029, 70010-030, 70010-031, 70010-032, 70010-033, 70010-034
UPC0370010029019, 0370010030015, 0370010032019, 0370010034013, 0370010031012, 0370010033016
Quantity recalled9,917 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0671-2025
FDA event ID
97504
Recalling firm
Granules Pharmaceuticals, Chantilly, VA
Manufacturer
Granules Pharmaceuticals Inc.
Classification
Class III
Status
Ongoing
Recall initiated
28 Aug 2025
FDA classified
24 Sep 2025
Reported
1 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay
Drug class
ADHD Medication

Timeline

28 Aug 2025Recall initiated by company
24 Sep 2025Classified by FDA+27 days
1 Oct 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications:

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01

Where it was distributed

Distributed Nationwide in the USA

Nationwide

Questions about this recall

Is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine recalled?

Yes. Granules Pharmaceuticals recalled Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine on 28 Aug 2025. The recall is Class III and its status is Ongoing. Recall number D-0671-2025.

Why was it recalled?

Failed Impurities/Degradation Specifications:

Which lots are affected?

Lot#: GPC250178A, Exp Date: 06-22-2027

Where was it sold?

Distributed Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Granules Pharmaceuticals

All 11
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITrazodone Hydrochloride, USP, 50 mg recalled by Granules PharmaceuticalsTrazodone HydrochlorideGranules PharmaceuticalsOtherNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recalls

All 11
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by ANI PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateANI PharmaceuticalsOtherNationwide